logo

The COVID-NMA initiative
A living mapping and living systematic review of Covid-19 trials

COVID-NMA is an international research initiative supported by the WHO and Cochrane.

We provide a living mapping of COVID-19 trials. We are also conducting living evidence synthesis on preventive interventions, treatments and vaccines for COVID-19 to assist decision makers.

See the description of our model here and our living review protocol here.

LIVING MAPPING OF TRIALS

(i.e., trials registered on the WHO platform)
Updated weekly

4409
Randomized Trials
1295 RCTs recruiting

3395
RCTs on treatments
(984 recruiting)

373
RCTs on prevention
(88 recruiting)

641
RCTs on vaccines
(223 recruiting)

LIVING SYNTHESIS OF PUBLISHED STUDIES

(include both articles and preprints)
Updated daily

790
Studies (RCTs or Observational studies) with complete data extraction and results
included in our evidence synthesis

524
RCTs on treatments

17
RCTs on prevention

154
RCTs on vaccines

95
observationnal studies on vaccines

meta-COVID

Perform your own analysis using COVID-NMA data, create and download your forest plots by clicking below:

go to metacovid

Summary of Main Results

Summary of the evidence for treatment of hospitalized COVID-19 patients identified up to August 3, 2022 is available below.
It will be updated monthly.

Summary of Main Results

For earlier editions of the summary of main results, click here

BI-WEEKLY UPDATE

July 23 to August 05, 2022. see the update here.

Newsletter

To receive updates on our project, please subscribe below.

Excluded Studies

Download CSV file (last update: 2022-03-14).

Retracted Studies

Download CSV file (last update: 2022-08-10).

This work received some funding from the Agence Nationale de la Recherche (ANR), the World Health Organization (WHO), Cochrane France, Center of Research in Epidemiology and StatisticS (CRESS), Centre d’Epidémiologie Clinique (GHU Cochin, Hôtel Dieu), the French Ministry of Higher Education and Research, the French Ministry of Health, Assistance Publique Hôpitaux de Paris (APHP), Université de Paris Cité, Centre national de la recherche scientifique (CNRS), the Federal Ministry of Education and Research, Germany and the European Union's Horizon 2020 Research and Innovation Programme under agreement No. 101037867.